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Introduction: Bursitis is a rare complication of brucellosis that has only once been described in
a country where disease has been eradicated in domestic animals.
Case Presentation: A 63-year-old diabetic man presented with an 11-year history of painless
swelling over his right knee. Magnetic resonance imaging (MRI) showed a large, multiloculated
cyst overlying the knee joint. The patient underwent bursectomy which revealed caseous
necrosis. Operative samples cultured Brucella abortus. The patient was treated with a
combination of surgery and antimicrobials (doxycycline, rifampicin and gentamicin). His only risk
factor for acquiring Brucella was drinking unpasteurized milk during childhood. Fifty eight cases
of Brucella bursitis have been described in the English-language medical literature. Half have
involved the prepatellar bursa. Only one case, from Australia, occurred in a country that has
eradicated brucellosis in domestic animals. Although symptoms are often prolonged, local
features of inflammation are usually absent. Diagnosis is primarily by bursal fluid culture.
Treatment involves antimicrobials with or without aspiration or excision of the bursa. As the
diagnosis was unexpected, several laboratory workers were exposed to the Brucella isolate
before its identification. Follow up according to UK guidelines revealed no cases of
occupationally acquired infection.
Conclusion: Bursitis is an unusual manifestation of brucellosis. It is extremely rare outside
countries where the infection is endemic, but the chronicity of symptoms and increase in global
travel mean that patients with the condition may present in non-endemic settings. Clinicians
should therefore consider the diagnosis in cases of unexplained chronic bursitis.
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Introduction
Brucellosis is a zoonotic infectionwhich is classically charac-
terized by undulating fever and constitutional upset (Corbel
& Beeching, 2011). Osteoarticular infection is common,
occurring in 23–45 % of patients (Tas¸ova et al., 1999;
Mousa et al., 1987; Pourbagher et al., 2006; Gonza´lez-Gay
et al., 1999; Colmenero et al., 1996). Sacroiliitis, vertebral
osteomyelitis, discitis and large joint inflammatory arthritis
are the usual manifestations, whilst bursitis accounts for justAbbreviation: MRI, magnetic resonance imaging.
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1–7 % of bone and joint disease. Only 58 cases have been
described in the English language literature over the past
100 years (see Table 1) and this figuremay have been inflated
by repeated reporting of a number of cases (Johnson &
Weed, 1954). Apart from one case from Australia (Davis &
Broughton, 1996), all of the reports have come from
countries where brucellosis remains endemic in domestic
animals.
We describe the first case of Brucella bursitis in England,
where brucellosis in domestic animals has been eradicated.
As the cause was unexpected, the diagnosis was delayed
and a number of laboratory staff were exposed to the isolate
before it had been identified. By reporting this case and
reviewing the associated literature to highlight common
features of the condition, we hope that clinicians in
non-endemic countries will consider brucellosis in any unex-
plained chronic bursitis. This should ensure that the diagnosis
ismade earlier and that laboratory staff can take the necessary
precautionswhen handling both clinical samples and uniden-
tified bacterial isolates.
Case report
Thepatientwas a 63-year-oldCaucasianmanwith a history of
non-insulin dependent diabetes mellitus and hypertension.
He was a retired high school teacher who had consumed
unpasteurized milk whilst holidaying in the Republic of
Ireland during childhood. The patient holidayed annually at
a hotel in Jersey from 2001 to 2011. His only travel outside
the UK was to the Pyrenees in 1989. In 2000, he noted a pain-
less swelling over his right knee. It slowly enlarged over the
following years, until he was seen by an orthopaedic surgeon
in 2005. A diagnosis of a simple cyst was made on the basis
of clinical examination and magnetic resonance imaging
Table 1. Cases of Brucella bursitis published in the English-language literature
Reference Number of
bursitis cases
Total number of
patients in series
Site(s) of infected
bursa(e)
Species (n)
Kennedy (1904) 1 1 Subdeltoid Not reported (probable
B. melitensis)
Johnson & Weed (1954) 4 4 Prepatellar B. abortus
Rote´s-Querol (1957) 3 174 Olecranon (two cases) Not reported
Greater trochanter (1)
Schirger et al. (1960) 3 224 Prepatellar B. abortus (2)
B. suis (1)
Kelly et al. (1960) 8* 36D Prepatellar B. abortus (6)
B. suis (2)
Ariza et al. (1985) 3 331 Not reported Not reported
Mousa et al. (1987) 1 452 Olecranon Not reported
Colmenero et al. (1991) 2 263 Olecranon Not reported
Gonza´lez-Alvaro et al. (1994) 1 2 Olecranon (bilateral) B. melitensis
McDermott et al. (1994) 1 1 Suprapatellar B. abortus
Solera et al. (1996) 2 64 Prepatellar d Not reported
Davis & Broughton (1996) 1 1 Prepatellar B. abortus
Gonza´lez-Gay et al. (1997) 1 1 Prepatellar B. abortus
Garcı´a-Porru´a et al. (1999) 3* (75 cases of
septic bursitis)
Not reported B. abortus
Gonza´lez-Gay et al. (1999) 3 158 Prepatellar (2) B. abortus
Olecranon (1)
Tas¸ova et al. (1999) 5 238 Prepatellar (3) Not reported
Subacromial (2)
Guiral et al. (1999) 1 1 Iliopsoas B. melitensis
Pourbagher et al. (2006) 131 251 Suprapatellar (6) Not reported
Olecranon (3)
Subacromial (3)
Lateral malleolus (1)
Traboulsi et al. (2007) 1 1 Prepatellar B. melitensis
Wallach et al. (2010) 1 1 Prepatellar B. abortus
*Number likely to include some previously reported cases.
DCases of osteoarticular brucellosis only.
dUnclear if one or both cases involved the prepatellar bursa.
1Bursitis diagnosed radiologically.
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(MRI). The patient declined an offer of surgical excision.
Following this, the lesion continued to enlarge, eventually
causingminor restriction of knee flexion. The patient reported
experiencing night sweats approximately once per month
during this period but no other constitutional symptoms.
In March 2011 he experienced an episode of cellulitis over
the knee, precipitated by a carpet burn sustained when he
fell at home. The cellulitis was treated with oral flucloxacillin
and he was referred back to the orthopaedic surgeon.MRI in
April showed a 15 cm multiloculated cyst encasing the
anterior aspect and sides of the knee, lying in the soft
tissue over the quadriceps muscles and patellar tendon
(Fig. 1). The radiological impression was of severe chronic
bursitis. Threemonths later, the patient again developed cel-
lulitis of the skin overlying the lesion. Clinical examination
at that time revealed an associated sinus. A superficial
swab isolated Streptococcus agalactiae (Lancefield group B).
Again, the cellulitis responded to flucloxacillin. In August
2011, a biopsy was taken for histological examination. This
showed necrosis with areas of both acute and chronic
inflammation, consistent with an infected prepatellar
bursa. No sample was sent for culture. One month later,
the patient underwent complete excision of the lesion.
At surgery, there was extensive caseous necrosis.
Investigations
Three samples of tissue and one of pus were negative
on Gram and auramine staining. They were cultured on
chocolate, Columbia blood and cysteine lactose electrolyte
deficient agar (all from Oxoid) at 36 uC in aerobic con-
ditions (supplemented with carbon dioxide for the choco-
late and blood agar). They were also cultured on fastidious
anaerobe agar (FAA; E&O Laboratories) at 36 uC in
anaerobic conditions. For each tissue sample, an anaerobic
broth culture was set up which was subcultured to choco-
late, FAA and neomycin agar on 3 consecutive days, after
5 days incubation. All of the tissue samples isolated Serra-
tia marsescens and a coagulase-negative Staphylococcus.
After 72 h incubation, colonies of a small Gram-negative
cocco-bacillus were noted on the blood and chocolate agar
plates from all samples. The organism was identified by
using a VITEK 2 system (Bio Merieux) as Brucella melitensis
(98 % probability). Subsequent PCR of the 16S rRNA gene
generated a 609 bp sequence that had 100 % similarity
with Brucella spp. sequences published on the BLAST data-
base. The Animal and Plant Health Agency Reference
Laboratory (Weybridge, England) identified the organism
as Brucella abortus biovar five. Serological testing of the
patient’s blood at the Brucella Reference Unit (Liverpool,
England) showed a Brucella IgG titre of w1 : 2560 and
IgM titre ofv1 : 20. No follow up testing was performed.
Treatment
The patient was initially given oral ciprofloxacin, 500 mg
twice daily, to treat the Serratia superinfection. Following
the identification of Brucella, this was switched to oral
(b)(a)
Fig. 1. T2-weighted sagittal (a) and coronal (b) MRIs of the right knee, showing a large cystic lesion overlying the quadri-
ceps muscles and patellar tendon.
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doxycycline 100 mg twice daily, oral rifampicin 600 mg
once daily and intravenous gentamicin 7 mg kg21 body
weight once daily. After 19 days of antimicrobial therapy,
the patient underwent split skin grafting. The gentamicin
was stopped at 2 weeks. The original plan was to give the
patient a total of 12 weeks oral antibiotics, but treatment
was stopped after 6 weeks due to persistent nausea.
Outcome and follow-up
The patient was discharged from follow-up after 11 months,
and at 3 years has had no evidence of relapse.
Discussion
Brucella bursitis was first described in 1904 by Kennedy
(1904). The condition has parallels with fistulous withers
in horses (Cohen et al., 1992). Early published cases are
mostly from the USA (Johnson & Weed, 1954; Schirger
et al., 1960; Kelly et al., 1960). More recent reports come
from northern Spain, Turkey and Kuwait (Tas¸ova et al.,
1999; Mousa et al., 1987; Pourbagher et al., 2006;
Gonza´lez-Gay et al., 1999). This is consistent with the cur-
rent global epidemiology of brucellosis, which remains
endemic in parts of the Mediterranean and the Middle
East (Corbel & Beeching, 2011).
Brucellosis has been described involving a number of
bursae (Table 1). Previous reviewers have suggested that
the olecranon bursa is the most common site (Akhvlediani
et al., 2011) but our review of the literature has revealed
more cases of prepatellar bursitis.
In 1954, Johnson & Weed (1954) published the first com-
prehensive description of four cases of prepatellar bursitis.
Six years later, the same group included eight cases in a series
of osteoarticular brucellosis (Kelly et al., 1960). It is unclear
if the patients from the original report were included in this
number. Since that paper, there have been a further four
single case reports (Davis & Broughton, 1996; Gonza´lez-
Gay et al., 1997; Traboulsi et al.; 2007; Wallach et al.,
2010). All of these patients have had prepatellar bursitis as
the only or main manifestation of Brucella infection. All
but one of the cases occurred in men, perhaps reflecting
an increased risk of exposure through occupation. In the
majority of cases (6/8) the patients were farmers, in whom
local inoculation with Brucella may have occurred dur-
ing recurrent trauma from kneeling (Johnson & Weed,
1954). However, in one case, the route of infection was
the consumption of cheese made with unpasteurized milk,
suggesting haematogenous seeding of the bursa (Traboulsi
et al., 2007). We believe this is the mechanism by which
our patient acquired Brucella infection.
Despite the small number of cases of prepatellar bursitis due
to Brucella, several common features are evident (Table 2).
The first is the duration of symptoms before diagnosis.
Although cases are occasionally described as presenting
acutely (Akhvlediani et al., 2011), the majority of patients
with bursitis are symptomatic for much longer. Amongst
the cases of prepatellar infection, the duration of illness
ranges from 2 months to 14 years. This is consistent with
the observation in several case series that symptoms are
more prolonged in patients with osteoarticular forms of bru-
cellosis, compared to those without focal disease (Gonza´lez-
Gay et al., 1999; Schirger et al., 1960; Ariza et al.; 1985).
Table 2. Clinical features and treatment of prepatellar Brucella bursitis from case reports
Reference Gender Occupation Duration of
symptoms
Systemic
features
Local
inflammation
Treatment
Johnson & Weed
(1954)
Male
(four cases)
Farmers 8 months –
14 years
No No Bursectomy in all cases; aureomycin 3 g
and streptomycin 1 g daily for
6–30 days in three cases
Davis & Broughton
(1996)
Male Retired
farm
worker
2 months Yes N/K Doxycycline for 22 weeks and rifampicin
for the first 6 weeks (doses not stated)
Gonza´lez-Gay et al.
(1997)
Male Farmer 10 years No Yes* Streptomycin 1 g once daily for 3 weeks
and doxycycline 100 mg twice daily for
6 weeks plus bursectomy
Traboulsi et al.
(2007)
Female Housewife 1 year No No Streptomycin 1 g daily and doxycycline
100 mg twice daily for 2 weeks, then
doxycycline 100 mg and rifampicin
600 mg one daily for 8 weeks, with
recurrent aspiration
Wallach et al.
(2010)
Male Former
abattoir
worker
5 years Yes Yes Doxycycline 100 mg twice daily and
rifampicin 300 mg twice daily (both for
6 weeks)
* Patient had coinfection with S. agalactiae at presentation
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Fever and other constitutional symptoms are common in
brucellosis, both with and without osteoarticular involve-
ment (Tas¸ova et al., 1999; Mousa et al., 1987).
In contrast, in six of the eight detailed case reports of
pre-patellar bursitis, there was no history of fever or
other systemic upset (Johnson & Weed, 1954; Gonza´lez-
Gay et al., 1997; Traboulsi et al.; 2007). Infrequent night
sweats was the only systemic symptom our patient
described. In addition, local signs of inflammation are
usually mild or absent, except when secondary infection
is present (Gonza´lez-Gay et al., 1997). The indolent
nature of the Brucella bursitis may relate to the fact that
B. abortus is the commonest infecting organism
(Table 1). This species is classically said to be less virulent
than B. melitensis (Corbel & Beeching, 2011).
Diagnosis is usually achieved by culturing Brucella in syno-
vial fluid aspirated from the bursa (Gonza´lez-Gay et al.,
1999), though it is not always positive (Pourbagher et al.,
2006). In some cases of bursitis, the organism can also
be recovered from blood cultures (Garcı´a-Porru´a et al.,
1999). Serology is almost always positive at high titres in
patients with bursitis, as well as other osteoarticular compli-
cations (Mousa et al., 1987; Colmenero et al., 1991). In our
case, the diagnosis was not expected, and precautions to
limit the risk of exposing laboratory workers to Brucella (a
category 3 pathogen) were not taken during microbiology
processing of samples. Laboratory staff who were exposed
to this isolate of B. abortus were followed up in line with
UK guidance (Brucella Reference Laboratory, 2013). This
did not reveal any evidence of occupationally acquired
infection.
Treatment of Brucella bursitis involves antimicrobial
therapy with or without aspiration or bursectomy. Early
authors favoured surgical resection (Johnson & Weed,
1954; Kelly et al., 1960), but in more recent reports medical
treatment alone, sometimes with aspiration, has been suc-
cessful (Gonza´lez-Alvaro et al., 1994; Traboulsi et al., 2007;
Wallach et al., 2010). This most likely reflects improve-
ments in antimicrobial treatment for brucellosis. Our
patient underwent complete excision of the lesion before
the diagnosis had been made. Subsequent treatment was
with 6 weeks of oral doxycycline and rifampicin, with
intravenous gentamicin for the first 2 weeks. This combi-
nation was chosen in the basis of its efficacy in a meta-
analysis of brucellosis treatment trials (Skalsky et al.,
2008). Twelve weeks of therapy is advised when focal dis-
ease is present (Corbel & Beeching, 2011), but a variety of
both agents and treatment durations have been used for
bursitis (Table 2).
Bursitis is a rare but well-described complication of brucel-
losis. This case and review of the literature shows that
the diagnosis requires a high index of suspicion as clinical
features are often non-specific. The diagnosis should
be considered in cases of unexplained chronic bursitis,
even in countries where brucellosis has been eradicated
in domestic animals. Samples for microbiological analysis
should be collected and processed using appropriate
precautions to prevent exposure of laboratory staff to the
pathogen.
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